0 items USD 0.00Search
- Did you mean
- fibrosis drug
Your search for "sclerosis drug" gave back 75886 results.
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
颁补迟补濒辞驳:听
Global Markets Direct
November 2019
Price: USD 2,000.00
Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or...
颁补迟补濒辞驳:听
Global Markets Direct
August 2018
Price: USD 3,500.00
Multiple Sclerosis - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
颁补迟补濒辞驳:听
Global Markets Direct
June 2020
Price: USD 2,500.00
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
颁补迟补濒辞驳:听
Global Markets Direct
May 2020
Price: USD 2,500.00
Multiple Sclerosis - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
颁补迟补濒辞驳:听
Global Markets Direct
December 2019
Price: USD 2,500.00
Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or...
颁补迟补濒辞驳:听
Global Markets Direct
February 2018
Price: USD 3,500.00
The global market for Multiple Sclerosis Therapies was estimated to be worth US$ 22320 million in 2023 and is forecast to a readjusted size of US$...
颁补迟补濒辞驳:听
MRRPB5
November 2024
Price: USD 3,950.00
The global Progressive Relapsing Multiple Sclerosis Treatment market size was valued at US$ million in 2023. With growing demand in downstream market...
颁补迟补濒辞驳:听
LPI
August 2024
Price: USD 3,660.00
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig鈥檚 disease or Maladie De Charcot, it is a neurological disease that causes nerve cells...
颁补迟补濒辞驳:听
LPI
May 2024
Price: USD 3,660.00
The global Stem Cell Therapy for Multiple Sclerosis market size was valued at US$ million in 2023. With growing demand in downstream market, the Stem...
颁补迟补濒辞驳:听
LPI
December 2024
Price: USD 3,660.00
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks...
颁补迟补濒辞驳:听
MRRPB5
February 2024
Price: USD 2,900.00
The global market for Relapsing Multiple Sclerosis Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US...
颁补迟补濒辞驳:听
MRRPB5
November 2024
Price: USD 3,950.00
The global Multiple Sclerosis Therapeutics market size was valued at US$ 16660 million in 2023. With growing demand in downstream market, the...
颁补迟补濒辞驳:听
LPI
September 2024
Price: USD 3,660.00
The global Primary Progressive Multiple Sclerosis Treatment market size was valued at US$ million in 2023. With growing demand in downstream market,...
颁补迟补濒辞驳:听
LPI
August 2024
Price: USD 3,660.00
The global Amyotrophic Lateral Sclerosis Therapeutics market size was valued at US$ 293.5 million in 2023. With growing demand in downstream market,...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
听
